An open-label, prospective study to evaluate social function and overall improvement of extended-release paliperidone treatment in Thai schizophrenia patients
Chawanun Charnsil,1 Salinee Vongpanich21Department of Psychiatry, Chiang Mai University, Chiang Mai, Thailand; 2Medical Affairs Department, Janssen-Cilag, Bangkok, ThailandBackground: Previous studies with extended-release (ER) paliperidone have reported an effective outcome in terms of personal and...
Saved in:
Main Authors: | Charnsil C, Vongpanich S |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/7b276e8a2e404f87b4eff4ad30b12e26 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of paliperidone extended release on hostility among Thai patients with schizophrenia
by: Jariyavilas A, et al.
Published: (2017) -
An open-label, flexible-dose study of paliperidone extended-release in Chinese patients with first-onset psychosis
by: Si TM, et al.
Published: (2015) -
Direct and indirect effects of paliperidone extended-release tablets on negative symptoms of schizophrenia
by: Ibrahim Turkoz, et al.
Published: (2008) -
Treatment satisfaction with paliperidone extended-release tablets: open-label study in schizophrenia patients dissatisfied with previous antipsychotic medication
by: Yang FD, et al.
Published: (2017) -
The social functional outcome of being naturalistically treated with paliperidone extended-release in patients with schizophrenia
by: Nakagawa R, et al.
Published: (2015)